Drug Profile
Estradiol valerate/medroxyprogesterone triphasic
Alternative Names: Diviseq; Estradiol valerate + medroxyprogesterone acetate - Orion PharmaLatest Information Update: 06 May 2022
Price :
$50
*
At a glance
- Originator Orion
- Developer HRA Pharma; Orion
- Class Estradiol congeners; Estrenes; Hormonal replacements; Pregnenediones
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome
Most Recent Events
- 02 May 2022 HRA Pharma has been acquired by Perrigo
- 21 Oct 2003 Launched for Menopausal syndrome in Russia (PO)
- 17 Oct 2003 Launched for Menopausal syndrome in France (PO)